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THE IDENTIFICATION OF CONTACT ALLERGENS BY HUMAN
ASSAY
I. A CRITIQUE OF STANDARD METHODS*
ALBERT M. KLIGMAN, M.D., PH.D.
The development of an improved method
for screening and identifying new agents capable
of causing allergic contact dermatitis has been
the objective of a six year research program.
In this first report of a series, the shape and
dimensions of the problem are set forth and the
adequacy of current methods of detection
brought under experimental analysis.
Human skin is having an unprecedented
experience. An immense number and variety
of utterly novel substances produced by syn-
thetic chemists eventually reach the skin in
the form of cosmetics, drugs, household articles,
industrial chemicals, clothing and indeed, in
all the prodigious paraphernalia of modern times.
In a 'tour' through the modem home, S. Epstein
has inventoried hundreds of potential contact
allergens. (1). Man now lives in a complex
chemical environment depending, as always on
his skin for protection. Delayed hypersensi-
tivity, of which contact allergy is a classical
example, was probably developed phylogenet-
ically as a defense against invasion of mi-
crobes, arthropods, insects and myriads of tiny
pests searching for fulfilment beyond the skin
barrier. On its first experience with the alien
agent, the skin, innocent and unwary, puts up
no very strong objection. It can later acquire
an ability react, and subsequent exposures
bring forth reactions designed to dilute or cast
off the offender. In contact allergy to chemi-
cals, we observe the inappropriate, futile, way-
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ward and injurious expression of all stereo-
typed, unselective, catch-all defense mechanisms.
Contact allergy is an exceedingly common
disease. It is obvious that new substances
destined for intimate skin contact must be
certified as innocuous, both with regard to ir-
ritancy and allergenicity. Even weakly sensitiz-
ing substances may cause widespread indisposi-
tion. For instance, a cosmetic which sensitizes
one of 1,000 of its 10,000,000 users will cast up
10,000 cases of contact dermatitis. How can
we devise a test sensitive enough to forewarn
against a sensitization rate of 0.1% or less?
We shall review how the problem has been
handled thus far.
An experimental experience with more than
12,000 adult humans forms the foundation of
the present reports. The subjects have been
inmate volunteers of the Philadelphia County
Prison at Holmesburg. Scores of different al-
lergens of varying sensitizing capacity have
been investigated.
APPRAISAL OF TEST METHODS
Usage: At the outset it should be realized
that only one method provides certainty in
predicting the incidence of sensitization,
namely usage. The use of this method for
weaker allergens requires populations of enor-
mous size for statistical satisfaction. Cost alone
dismisses serious consideration; moreover,
how is one to warrant that thousands of sub-
jects have indeed used the product scrupulously,
and in exactly the prescribed way for the
specified period?
In consequence, various forms of human bio-
assay have been devised. These utilize patch
test exposures of a sample group from which
the likelihood of sensitization in the population
at large is predicted.
The Schwartz-Peck Test (2)
This was the first to find wide application. It is
the least arduous and the simplest. Its specifica-
tions are:
1. Two hundred subjects; the test material is
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applied to a ¼" piece of 4-ply gauze. The
'standard patch' is occlusive, the gauze being
covered with a water-proof backing and
sealed to the skin of the arm or back by
means of adhesive tape.
2. Standard patch applied for 24—48 hours.
Reading of the site for the next few days es-
tablishes whether or not the product is a pri-
mary irritant.
3. Rest period of 10—14 days.
4. Repeat standard patch test for 24—48 hours.
The emergence of a dermatitis not present
the first time signifies sensitization.
Literal reading of the reactions may lead to mo-
mentous errors (3). Rostenberg, in a review of the
problem of predictive patch testing (4), found that
the S-P technic was a good one as originally out-
lined, but that it has suffered an 'emasculation'
which vitiates its worth. According to him, a con-
comitant four week usage test was required, but the
original procedure was described for the testing of
cosmetics only. The S-P procedure encompasses
only patch testing. Later, however, investigators
included usage. We may therefore term the origi-
nal procedure the incomplete Schwartz-Peck test;
the complete Schwartz-Peck test includes usage
for three to four weeks. For example, in addition
to patching, a lipstick would be applied with the
usual frequency to the prescribed area; a shampoo
perhaps once or twice weekly to the scalp, an anti-
perspirant daily to the axilla, etc. Schwartz and
Peck are confident that this method will 'foretell'
whether a substance will sensitize. They call it the
'prophetic' patch test. The implicit promise is that
path test bioassay in a comparatively small sample
will foretell the incidence of sensitization in one
of indefinite size, a prognostication not validated
by data.
Traub-Tusing-Spoor Method (5)
Mention of this procedure serves only the in-
terest of history. It is in fact the 'complete'
Schwartz-Peck test. Between the initial and final
patches is inserted three weeks of appropriate
usage.
Brunner-Smiljanic Test (6)
This is essentially the complete Schwartz-Peck
test stripped of the initial and final patches. It is
a straight usage procedure requiring five days of
daily use, one week rest, and reapplication for sev-
eral more weeks.
Repeated Insult Tests
Draize and the Shelanskis independently pub-
lished methods which have come to be known as
the 'repeated insult' test or the 'Draize-Shelanski'
test. In the interest of accuracy, this fusion is un-
warranted. Although some experience was evi-
dently shared, these tests are genuinely different.
A. The Draize Test (7)
This seems to be patterned after the original
Landsteiner guinea pig technic. The specifications
are:
1. Two hundred subjects: standard patch tests
using 0.5 gm of test material on 1" squares.
2. Apply patch 24 hours.
3. Rest 24 hours.
4. Reapply patch on a new site for 24 hours.
5. Rest 24 hours.
6. Repeat for a total of 10—24 hour exposures,
applying patches to new sites.
7. Rest 10—14 days.
8. Challenge patch test in a fresh site to deter-
mine sensitization.
B. Shelanski-Shelanski Test (8)
The resemblance of this test to the Draize Test
is obvious but the differences are important.
1. Two hundred subjects: Standard Patch Test.
2. Apply patch 24 hours.
3. Rest 24 hours.
4. Reapply patch to same site for 24 hours.
5. Rest 24 hours.
6. Repeat for a total of 15 exposures to the same
site.
7. Rest 2—3 weeks.
8. Challenge patch test in a fresh site to deter-
mine sensitization.
The salient differences between this and the
Draize test are the use of 15 instead of 10 expo-
sures and, most importantly, all exposures are
made to the very same site. This specification has
the purpose of revealing what the authors unf or-
tunately term the 'fatigue reaction', by which they
mean irritant reactions which appear only after
repeated exposure. Skin 'fatigue' is, of course, an
inappropriate and misleading term for a well-
known phenomenon, namely chronic or cumula-
tive irritation. But precisely because irritation, or
at least maceration, is more likely when the same
site receives 15 patches, the Shelanskis, as will be
seen, have devised a better test.
It should be noted that the repeated insult tests
were intended to evaluate finished formulations
and materials as they would be used. Moreover,
information is provided for irritation as well as
sensitization.
CRITICISM OF PREDICTIVE TESTS
How do authors of these tests know that
they are predictive? How well do they perform
in warning against the risk of sensitization?
Are known allergens readily detected by these
technics? Hundreds, perhaps thousands, of
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preparations have been screened by these pro-
cedures, but the results have not been published.
The literature contains no study which demon-
strates the comparative effectiveness of these
tests for even one substance.
The issue can be framed in a single ques-
tion. Have the tests been tested? Since no for-
mal data are available, we shall first examine
the question in the light of certain illuminating
clinical experiences and additionally, statis-
tical theory. Finally, we shall see what happens
when these tests are applied to agents whose
capabilities for inducing contact sensitization
are reasonably well known.
CLINICAL EXPERIENCE
Two products were marketed which had
calamitous cutaneous effects. Both, according to
reputable manufacturers, has passed repeated
insult tests. The first, an undercoat for nail
polish (Everon) was a resin which caused a
considerable inflammatory reaction of the nail
bed leading to hemorrhage and separation (9).
An allergic etiology was postulated but was
never unassailably established; first because it
was hard to believe that the resin could pene-
trate entirely through the highly impermeable
nail plate and second because patch testing of
affected individuals usually gave negative re-
sults (10).
Using the 'maximization' procedure which
will be described in a following paper of this
series, I established that these reactions were
truly allergic owing to the presence of uncured
resins. The commercial undercoat sensitized
more than 50% of a test group of 25 sub-
jects. When completely cured, the allergenicity
was completely removed. An effective screen-
ing procedure would have forewarned the diffi-
culty and proposed the solution to the manu-
facturer, namely complete curing.
The second agent whose allergenic potentiality
was not foreseen by repeated insult tests was
tetrachlorosalicylanilide (TCSA), an excellent
bacteriostatic agent which was incorporated
into soap. Immediately after its distribution, it
caused a large incidence of photosensitivity in
England (11). However, many of these sub-
jects had acquired a simple contact sensitiza-
tion and reacted to unirradiated patch tests
(12). This agent had been thoroughly scru-
tinized in anticipation of its widespread use.
Multiple insult tests (Draize) had been per-
formed on a good many more subjects than 200
using one to five percent concentrations in al-
cohol and in synthetic detergents, although
the concentration in soap itself was usually
less than 0.5%.* This is a particularly telling
case since adequate testing could have shown
that tetrachiorosalicylanilide is a very potent
contact sensitizor. An adequate screening proce-
dure would have led to categorical rejection of
this agent in a product as widely used as soap.
STATISTICAL CONSIDERATIONS
The implicit assumption of predictive tests
is that the results with 200 test subjects will
apply to the population at large. The mathe-
matical disabilities of such a proposition are
great. Leaving aside biological issues, statistical
principles are sufficient to decide the amount of
confidence which can be placed in such a state-
ment as Shelanski's: "It is when a substance
shows up negatively in 200 subjects that the
prophetic patch test issues its prophecy, that
it is probably safe to have the material come
in contact with a large group of subjects" (13).
Henderson and Riley have analyzed the pre-
dictive qualities of these tests mathematically
(14). Additionally, at Rostenberg's behest,
Knudsen examined the probabilities of finding
hypersensitive subjects in random groups ac-
cording to statistical principles (15). These
workers arguing mathematically, not biologically,
have illustrated the difficulties in interpreting
so-called predictive procedures.
Two kinds of statistical problems present
themselves:
1. If we actually know what the rate of sen-
sitization is, how large a test group will we need
to assure ourselves within certain limits of con-
fidence, traditionally 95%, that the correspond-
ing rate in the user population will not
exceed a certain maximum? Suppose, for in-
stance, that the test group of 200 subjects con-
tains no reactors. From the manufacturer's
standpoint this is the most cheerful result
possible. Need he worry? The fact is however
that he can extract no more security from this
outcome than that not more than 1.5% of
the general population will become sensitized.
In only exceptional circumstances would a
* Information provided by the Geigy Corpora-
tion, supplier of TCSA.
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manufacturer of a widely used preparation risk
sensitizing 15 persons in one thousand. Sup-
pose further that we can tolerate no more than
one case of sensitization per thousand users.
How many subjects must be tested with a
negative result before we can be certain that
this tolerance is not exceeded? The answer is
29,978 test subjects among whom there will not
even be one reactor!
As if to emphasize the above, we may take
notice of a recent querulous article in the
Journal of the American Medical Association
by one of the eminent pharmacologists in
America (16). Goodman had the highly per-
sonal experience of becoming sensitized to
'Scotchguard', a fabric finisher. He was in-
formed that the material had passed the 200
subject testing procedure. With the fervor of
the academician, he statistically deduced
that one would have to test a population of
25,000 persons among whom there would be no
reactors to be assured that there would not be
a user incidence of more than one in 5,000, a
reasonable level of risk, and he concluded that
"no adequate clinical examination of the po-
tential dermal toxicity of Scotchguard was
made before releasing it into the channels of
commerce." The channels will surely stagnate if
we must test every new material on 25,000
subjects! (nonetheless, it is a wry fact that
Scotchguard is safe!)
2. The second statistical issue is complimen-
tary to the first and no less troublesome. Sup-
pose we decide before hand that we will accept
a certain maximum incidence in the popula-
tion such as 0.1% and we have available any
number of homogeneous test groups of 200 sub-
jects each. We would find that about 80% of
such groups would have no reactors; that is,
four out of five times we would not learn that
the product had actually a prohibitive rate of
sensitization. Statistically, only one of 50
groups of 200 would confidently contain more
than one reactor!
APPLICATION OF PREDICTIVE TESTS TO
KNOWN CONTACT ALLERGENS
The correlation between predictive test
scores and later marketing experience for a
large number of substances could, with quali-
fications, provide a measure for judging the
adequacy of such tests. This data is buried
or unattainable. There is, however, a means of
retrospective analysis which permits one to
find out if such tests are biologically sound. This
is simply the testing of agents whose sensitizing
capacities have become rather well defined
through extensive use. Certain substances have
been 'black-listed' and the allergic risks at-
tending their use widely advertised. We can
test the predictive tests by seeing what verdict
they render for substances which have already
been condemned.
The following study was carried out on
prisoner volunteers:
Four predictive procedures were assessed:
(1) The incomplete Schwartz-Peck, (2) The
complete Schwartz-Peck (Traub-Tusing-Spoor
test), (3) Shelanski and Shelanski, (4) Draize.
The specifications were rigorously followed.
Two hundred subjects were used through-
out. Ten substances were evaluated; five agents
were simultaneously evaluated on each of
two groups of 200 subjects. These substances
were known to be "moderately strong allergens"
whose allergenic activity should pose no diffi-
culty if the testing procedure were effective.
The patch consisted of a one inch square of
unwoven cloth (Webril-Curity) to which 0.5 gm
of the test substance in petrolatum was applied.
The concentrations were at least equal to, or
higher than, those in which these substances
are conventionally used. The patch was oc-
elusively sealed to the skin under overlapping
strips of impermeable plastic tape (Blenderm-
Minnesota Mining Corp.). The patches were
applied occlusively to the back. The three
weeks of 'usage' of the incomplete Schwartz-
Peck Test was accomplished by daily induction
of five grams of each ointment either over one
extremity or over the anterior trunk. This
may not be entirely appropriate usage in
the strict sense since these are mainly ther-
apeutic agents, ordinarily applied to diseased,
not normal, skin as in the present instance.
The results are presented in Table I. Even
a quick glance will demonstrate the inadequacy
of predictive tests. Their performance was so
poor that one wonders how they have escaped
complete repudiation.
The failure of the incomplete Schwartz-
Peck Test was total; the complete version was
not quite entirely valueless. The Draize proced-
ure is comparable to the complete Schwartz-Peck
test, just short of total uselessness. That the
Shelanski and Shelanski Test is better is self-
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TABLE I
Predictive patch tests
Test procedure
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Incomplete Schwartz-
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0/200
0/200
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9/200
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0/200
0/200
0/200
0/200
0/200
0/200
evident, but it does not begin to measure up to
the task. It registers a resounding zero for peni-
cillin, streptomycin, neomycin, benzocaine, Fura-
cm® and butyn sulfate.
DISCUSSION
This study demonstrates the deficiencies of
so-called predictive tests. Long suspected of
insensitivity, this has now been conclusively
verified by retrospective testing of known
allergens. There is no question that these tests
do not begin to fulfill their claims of prophecy.
A great variety of substances have some
capacity to sensitize some persons under some
conditions. The range of sensitizing potentiality
is great. Among the latter are potent sensitizers
such as dinitrochlorobenzene, poison ivy anti-
gens, p-nitrosodimethyl-aniline, etc., which may
sensitize more than 90% of the population by
a single exposure. These can be easily exposed
as allergens by almost any procedure in a test
sample of 15 subjects. At the other pole are
weak allergens like lanolin, petrolatum, metallic
gold, etc. Examples of sensitization to these
are extremely uncommon, if they do indeed
exist. No test can hope to measure such low
degrees of sensitizing powers except to decide
them to be safe. Between these are the sub-
stances whose allergenicity can doubtlessly be
disclosed and roughly estimated by appropriate
procedures. If all known substances could be
categorized according to sensitizing capabilities,
the great majority would be feeble sensitizers,
presenting no significant risk no matter how
extensively used, a minority would be weak to
moderate sensitizors, and a small percentage
would be serious cutaneous hazards. Strong
sensitizers are relatively so uncommon that
the complete absence of testing procedures
would have only occasional serious effects. It
should be remembered that only a very small
number of the large galaxy of synthetic chemi-
cals have actually been formally tested, and
yet the "safety record" is on the whole pre-
sentable.
Tests which are absolutely predictive are for
the present beyond practical accomplishment.
The prime need is to identify agents which,
though only moderately allergenic, might
easily exceed the allowable limits of safety.
The maximum amount of sensitization that
can be tolerated for many widely-used prod-
ucts is certainly not more than one case of
contact dermatitis per thousand users. Reliable
prediction in these circumstances is probably
unattainable. Emphasis must shift from
prophecy to the more practical objective of
identifying potential allergens. The aim is the
more modest one of screening individual sub-
stances, not complex products, for their rela-
tive allergenic potency under specified condi-
tions. A scheme for identifying and ranking
substances according to their sensitizing poten-
tialities will be presented in the last paper of
this series. The test screen must be sufficiently
fine to 'filter out' even quite weak allergens.
Once the allergenic potentiality is known with
rcsonable certainty, a judgement of risk might
be ventured after examining all the pertinent
variables.
SUMMARY
1. The adequacy of currently used predic-
tive tests for contact allergens has been exam-
ined: (1) the complete and incomplete
Schwartz-Peck Test, (2) the Draize repeated
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insult test and (3) the Shelanski and Shelauski
repeated insult test.
2. The predictive tests have been tested
by observing their performance with a series of
known, moderately strong allergens. High in-
sensitivity was demonstrated. In test groups of
200 subjects, not a single subject became dem-
onstrably sensitized to penicillin G, streptomy-
ci neomycin, benzocaine, Furacin and butyn
sulfate.
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